Settling time for changes in the median of the Folded Normal distribution. by Ariel Burman (20329776)

The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). by Peng-fei Han (694841)

The 160 differentially expressed proteins significantly elevated in the severe injury group compared to the mild injury group and their folding changes. by Huiyang Jia (14444661)

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …”

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

Overview of the WeARTolerance program. by Ana Beato (20489933)

“…<div><p>The stigma surrounding mental health remains a significant barrier to help-seeking and well-being in youth populations. …”

Side effects of vaccination that affected participants’ children. by Sara Saleh (6733619)

Actin-Targeted Magnetic Nanomotors Mechanically Modulate the Tumor Mechanical Microenvironment for Cancer Treatment by Xing Fan (88299)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

Sequence of <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

Subjects:

Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

Subjects:

PCA-CGAN K-fold experiment table. by Chao Tang (10925)

“…Experiments demonstrate that PCA-CGAN not only achieves stable convergence on a large-scale heterogeneous dataset comprising 43 patients for the first time but also resolves the “dilution effect” problem in data augmentation, avoiding the asymmetric phenomenon where Precision increases while Recall decreases. After data augmentation, the ResNet model’s average F1 score improved significantly, with particularly outstanding performance on rare categories such as atrial premature beats, far surpassing traditional methods like SigCWGAN and TD-GAN. …”

PCAECG-GAN K-fold experiment table. by Chao Tang (10925)

“…Experiments demonstrate that PCA-CGAN not only achieves stable convergence on a large-scale heterogeneous dataset comprising 43 patients for the first time but also resolves the “dilution effect” problem in data augmentation, avoiding the asymmetric phenomenon where Precision increases while Recall decreases. After data augmentation, the ResNet model’s average F1 score improved significantly, with particularly outstanding performance on rare categories such as atrial premature beats, far surpassing traditional methods like SigCWGAN and TD-GAN. …”